Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

1,955.00INR
23 May 2018
Change (% chg)

Rs-58.75 (-2.92%)
Prev Close
Rs2,013.75
Open
Rs1,989.95
Day's High
Rs1,992.75
Day's Low
Rs1,936.35
Volume
46,313
Avg. Vol
63,028
52-wk High
Rs2,788.00
52-wk Low
Rs1,888.00

Latest Key Developments (Source: Significant Developments)

Amarin Announces Patent Litigation Settlement Agreement With Teva
Friday, 25 May 2018 

May 24 (Reuters) - Amarin Corporation PLC ::AMARIN ANNOUNCES PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA.AMARIN - TEVA MAY FIRST BEGIN SELLING ITS GENERIC VERSION OF VASCEPA IN U.S. ON AUGUST 9, 2029, OR EARLIER UNDER CERTAIN CUSTOMARY CIRCUMSTANCES.AMARIN CORPORATION - ANNOUNCED SETTLEMENT AGREEMENT WITH TEVA PHARMACEUTICALS USA THAT RESOLVES AMARIN'S PREVIOUSLY REPORTED VASCEPA PATENT LITIGATION.  Full Article

India's Dr.Reddy's Labs March Qtr Consol Profit Down 19.4 Pct
Tuesday, 22 May 2018 

May 22 (Reuters) - Dr.Reddy's Laboratories Ltd ::MARCH QUARTER CONSOL NET SALES 34.46 BILLION RUPEES VERSUS 34.99 BILLION RUPEES LAST YEAR.MARCH QUARTER 2017 CONSOL NET PROFIT 3.38 BILLION RUPEES .MARCH QUARTER NET PROFIT 2.72 BILLION RUPEES .CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 3.59 BILLION RUPEES.RECOMMENDED FINAL DIVIDEND OF 20 RUPEES PER SHARE.SAYS CONCLUDED A CHALLENGING YEAR FOR CO WTH A RELATIVELY MUTED Q4 PERFORMANCE.PERFORMANCE IN QUARTER MAINLY ON ACCOUNT OF CONTINUING HEADWINDS IN U.S. MARKETS, TEMPORARY DROP IN SALES IN RUSSIA.ALL FIGURES ARE AS PER INDIAN ACCOUNTING STANDARDS RULES.  Full Article

India's Dr.Reddy's Labs March Qtr Consol Profit Down 3.3 Pct
Tuesday, 22 May 2018 

May 22 (Reuters) - Dr.Reddy's Laboratories Ltd ::MARCH QUARTER NET PROFIT 3.02 BILLION RUPEES.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 3.59 BILLION RUPEES.RECOMMENDED FINAL DIVIDEND OF 20 RUPEES PER SHARE.MARCH QUARTER CONSOL NET SALES 35.35 BILLION RUPEES VERSUS 35.54 BILLION RUPEES LAST YEAR.MARCH QUARTER 2017 CONSOL NET PROFIT 3.13 BILLION RUPEES.SAYS CONCLUDED A CHALLENGING YEAR FOR CO WTH A RELATIVELY MUTED Q4 PERFORMANCE.PERFORMANCE IN QTR MAINLY ON ACCOUNT OF CONTINUING HEADWINDS IN U.S. MARKETS, TEMPORARY DROP IN SALES IN RUSSIA.THE PROFIT ALERT WAS FIRST SOURCED FROM TV AND LATER CONFIRMED FROM A PRESS RELEASE ON THE BSE .  Full Article

Dr.Reddy's Laboratories Launches Melphalan Hydrochloride Injection In U.S.
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS LAUNCH OF MELPHALAN HYDROCHLORIDE FOR INJECTION IN U.S. MARKET.  Full Article

Dr.Reddy's Labs Disagrees' With U.S. Govt. Allegations On Drug Packaging Not Tested For Child Safety
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::DR.REDDY'S LABORATORIES 'FIRMLY DISAGREES' WITH U.S. GOVERNMENT ALLEGATIONS THAT CO SOLD PRESCRIPTION DRUGS IN U.S. IN PACKAGING NOT TESTED FOR CHILD SAFETY.NOT AWARE OF REPORTS THAT PRODUCTS CAUSED CHILDREN HARM AS A RESULT OF PACKAGING.  Full Article

Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD.  Full Article

Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT.  Full Article

Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GERMANY REGULATOR APPROVES CO'S CAPA PLAN.SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​.SAYS GERMANY REGULATOR TO RE-INSPECT DUVVADA FACILITY BY END-2018.  Full Article

Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​.Says FDA has explained that the inspection has not closed and site's status remains unchanged.Planning to request a re-inspection in 2018.  Full Article

Dr.Reddy's Labs ‍launches clofarabine injection in U.S.
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says ‍launch of clofarabine injection in U.S. market​.  Full Article

BUZZ-India's Dr. Reddy's Laboratories falls on bleak Q4 show

** Indian generic drugmaker Dr. Reddy's Laboratories Ltd falls as much as 3.2 pct to 1,945 rupees